C-5PRZMediwhale
retinal imaging, AI, cardiovascular risk assessment
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-5PRZ
C-5PRZC-5PRZretinal imaging, AI, cardiovascular risk assessment
0-100 chain-logic scale · 15 dimensions · scored on public evidence
How Oculomics is Changing Patient Care | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upco
Mediwhale CEO Turns Glaucoma Diagnosis Into AI Healthcare Venture - Seoul Economic Daily Skip to main content Seoul Economic Daily Markets Property Finance Business Technology Politics Society Culture Sports International Opinion AI KEY Seoul Economic Daily KST Seoul Economic Daily Korea's Leading Business News Since 1960 한국어 Markets Property Finance Business Technology Politics Society Culture Sports International Opinion AI KEY Menu Saved Articles Newsletters AI KEY Settings Mediwhale CEO Turns Glaucoma Diagnosis Into AI Healthcare Venture News | Published 2026.03.12. 07:01:05 | By Lee … s "typical" engineering student's primary interest was "the application of technology." He recalled, "I was always thinking about how I could bring what I learned in engineering school to the world." The startup quickly became reality. Choi founded the company with Lim Hyung-taek, former professor of ophthalmology at Severance Hospital, who had diagnosed his glaucoma. While the energetic young man in his twenties provided drive, Professor Li … tive test in cardiology. Late last year, Mediwhale submitted a De Novo approval application to the U.S. Food and Drug Administration for Dr. Noon. "De Novo" means "new" in Latin and is a certification track that grants first-time approval after reviewing the safety and efficacy of innovative medical technologies that didn't previously exist. Mediwhale is the first in Korea's medical AI industry to pursue this track. "We could have chosen the … Korean capital markets coverage, translated. Subscribers see M&A, IPOs, and fund flows often before global wires. Pre-register → 50% intro rate at launch Related Articles Foreigners Dump 47 Trillion Won in Korean Stocks in May, Fifth Straight Month Published 2026.06.26. 06:01:05 As Samsung, SK Battle Over HBM, China Eats Into Commodity Memory Market Published 2026.06.26. 06:00:05 Insurers' Overseas Alternatives Hit 52 Trillion Won; S&P Warns of Lagged Detection P … es Coach, Bans Players' Social Media After 1-5 Rout 4 Seoul Subway Rejects Proposal to Show Exit-Door Direction Arrows 5 Europe's Worst Heatwave in 45 Years Halts Trains, Closes Schools ← Back to Home AI PRISM Podcast Spotify ↗ AI PRISM Korea's Property Market Fractures: Suburbs Surge As Loan Caps Near Failure | June 25 2026 00:00
[Interview] Mediwhale pushes for FDA approval to bring AI retinal scan to US cardiovascular prevention 주요서비스 바로가기 본문 바로가기 매체정보 바로가기 로그인 바로가기 기사검색 바로가기 전체서비스 바로가기 잠깐! 현재 Internet Explorer 8이하 버전을 이용중이십니다. 최신 브라우저(Browser) 사용을 권장드립니다! ie 인터넷 익스플로러 11 다운로드 chrome 구글 크롬 다운로드 firefox 모질라 파이어폭스 다운로드 상단영역 UPDATE : 2026-06-25 17:01 (Thurs) Home Log in Join 전체메뉴 기사검색 검색 본문영역 이전 기사보기 다음 기사보기 [Interview] Mediwhale pushes for FDA approval to bring AI retinal scan to US cardiovascular prevention 바로가기 복사하기 본문 글씨 줄이기 본문 글씨 키우기 스크롤 이동 상태바 현재위치 Home Device/ICT [Interview] Mediwhale pushes for FDA approva … ors for reimbursement in the U.S. healthcare system.” The company aims to submit its application by late 2025, with hopes for a decision by 2026. If approved, Dr. Noon CVD promises to detect cardiovascular risks early, facilitating preventive care in a country where nearly three-quarters of adults are overweight or obese. Rim highlighted the urgency of tackling cardiovascular-kidney-metabolic syndrome—a condition that links hypertension, diabetes, and dyslipidemia … forming Biosplice drug in animal tests Comments Log In 작성자 비밀번호 댓글 내용입력 0 / 400 Submit 댓글 정렬 Newest Recommended Top Comments BEST Comments BEST Comments It is automatically exposed by adding up the number of replies and recommendations. 닫기 More Delete comments Deleted comments cannot be recovered. Do you still want to delete it? Password Delete 닫기 Modify the comments You can modify comments only within 1 minute after writing. Text / 400 Password Modify 닫기 My comme
Founder Story | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Co … t From left, Young Lee(CTO), Dr. Tyler Rim(CMO), Kevin Choi(CEO) To enhance the application of machine learning they were on the lookout for the right Chief Technology Officer. Choi participated in big data conferences and competitions in healthcare and met Young Lee in 2016 who won the Big Data Health & Science competition hosted by Asan Medical Center, the biggest hospital in Korea, as a solo participant. With Young on board, Mediwhale’s foundational diagnostics algorithm t
AI eye examination reveals ‘cardiocerebrovascular disease’ risk: A trio aiming for global impact | Mediwhale LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, y
Mediwhale CEO Turns Glaucoma Diagnosis Into AI Healthcare Venture - Seoul Economic Daily Skip to main content Seoul Economic Daily Markets Property Finance Business Technology Politics Society Culture Sports International Opinion AI KEY Seoul Economic Daily KST Seoul Economic Daily Korea's Leading Business News Since 1960 한국어 Markets Property Finance Business Technology Politics Society Culture Sports International Opinion AI KEY Menu Saved Articles Newsletters AI KEY Settings Mediwhale CEO Turns Glaucoma Diagnosis Into AI Healthcare Venture Finance | Published 2026.03.12. 07:01:05 | By L … s "typical" engineering student's primary interest was "the application of technology." He recalled, "I was always thinking about how I could bring what I learned in engineering school to the world." The startup quickly became reality. Choi founded the company with Lim Hyung-taek, former professor of ophthalmology at Severance Hospital, who had diagnosed his glaucoma. While the energetic young man in his twenties provided drive, Professor Li … tive test in cardiology. Late last year, Mediwhale submitted a De Novo approval application to the U.S. Food and Drug Administration for Dr. Noon. "De Novo" means "new" in Latin and is a certification track that grants first-time approval after reviewing the safety and efficacy of innovative medical technologies that didn't previously exist. Mediwhale is the first in Korea's medical AI industry to pursue this track. "We could have chosen the … Korean capital markets coverage, translated. Subscribers see M&A, IPOs, and fund flows often before global wires. Pre-register → 50% intro rate at launch Related Articles Korea Premarket Rallies on Micron's Record Earnings as Chip Stocks Surge Published 2026.06.25. 08:15:22 Korea's Big Three Department Stores Near 1 Trillion Won in Foreign Sales Published 2026.06.25. 07:49:45 Seoul's Small, Standalone Complexes Trapped in Unsold-Unit Cycle Published 2026.06 … es Coach, Bans Players' Social Media After 1-5 Rout 4 Seoul Subway Rejects Proposal to Show Exit-Door Direction Arrows 5 Europe's Worst Heatwave in 45 Years Halts Trains, Closes Schools ← Back to Home AI PRISM Podcast Spotify ↗ AI PRISM K-Defense Enters Stage Three: Local Production and Global Partnerships | June 25 2026 00:00 / 06:11 �
Mediwhale Secures $13.3M Series C to Expand Retinal AI Cardiovascular Software-Eyes 2027 KOSDAQ Listing - WOWTALE Skip to content Korean English Account Login News Wow Biz Search for: Search News | Latest Interview Funding WOWLetter bioHealth Venture Capital AI Government Mobility Contents Search Korean English News Wow Biz Search News | Latest Interview Funding WOWLetter bioHealth Venture Capital AI Government Mobility Contents bioHealth · Funding Mediwhale Secures $13.3M Series C to Expand Retinal AI Cardiovascular Software-Eyes 2027 KOSDAQ Listing 3/31/2026 ・ 이준희(John Lee) Mediwhale
Mediwhale eyes 2025 Saudi launch of AI retinal imaging for heart disease | HealthTechAsia Skip to content Search Search HealthTechAsia Independent intelligence on healthtech across Asia and the Middle East Home Interviews Policy Lens Reports Accessing Syria’s healthcare market: A practical guide for medtech companies Human-Centred Digital Health eBook Opinion News Partner Content Events MedTech World Middle East 2026 GITEX Global 2025 GITEX DIGI HEALTH & BIOTECH Thailand 2025 DigiHealthDayS-2025 About Our story Team Work With Us Contact Us By Matthew Brady Sep 29, 2025 0 Comments # AI # c … d cardiovascular risk assessment using our technology.” The company is actively rolling out Dr. Noon CVD across Italy’s Nefro Center, a medical network of 100 hospitals and over 1,000 specialists. Implementation is expected to continue throughout 2025. In the Middle East, partnerships are already underway. “We’re working closely with GluCare in Dubai,” Choi noted, “a clinic known for its collaborations with multinational pharma like Novo Nordisk and Dexcom. Their strong focus … efficient, proactive healthcare system.” Author Matthew Brady Matt Brady is an award-winning storyteller and strategic communications advisor. A native Englishman with global experience spanning China, Hong Kong, Iraq, Malaysia, Saudi Arabia, and the UAE, he founded HealthTechAsia and co-founded the non-profit Pul Alliance for Digital Health and Equity. He has led social media and communications initiatives for world leaders, corporations, and NGOs, and spearheaded editorial … Microsoft and Johnson & Johnson. He received the 2021 Medical Travel Media Award from the Malaysia Healthcare Travel Council and a Guardian Student Media Award in 2000. Connect with Matt on LinkedIn: https://www.linkedin.com/in/matt-brady-0764992/ View all posts Discover more from HealthTechAsia Subscribe to get the latest posts sent to your email. Type your email… Subscribe Post navigation How TALOS Corp.’s ANRISK AI is detecting brain aneurysms before symptoms ap
66 Innovative Medical Imaging Companies to Follow in 2023 | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles … unding year: 2014 – Headquater(s): Göteborg, Vastra Gotaland, Sweden – Funding: Grant 8. CARE MENTOR AI CARE MENTOR AI Care Mentor AI is a valuable service for interpreting radiological studies (CT, MRI, X-ray, etc.) built on a medical neural network. Care Mentir AI develops an artificial intelligence system for analyzing and interpreting the results of radiation research methods. – Founder(s): Pavel Roytberg – Founding year: 2018 – Headquater(s): Moscow, Moscow City, Russian … ng as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians worldwide to make better life-saving decisions. – Founder(s): Andrew Barker, Michalis Papadakis – Founding year: 2010 – Headquater(s): Oxford, Oxfordshire, United Kingdom – Funding: Series B 10. Prognica Labs Prognica Labs Prognica, an AI-powered health-tech company, aims to improve clinical outcomes and accelerate the discovery of … ahmoud – Founding year: 2016 – Headquater(s): Gizah, Al Jizah, Egypt – Funding: Grant 14. QMENTA QMENTA QMENTA is a software platform for imaging-based clinical studies. Their solutions include data management systems, clinical trials, neuroimaging disease packages, neuro research, clinical care, and neuro-data services. Their cloud-based software solutions enable and build medical imaging management. – Founder(s): Landon McKenna, Paulo Rodrigues, Vesna Prčkovska – Founding y … lo – Founding year: 2013 – Headquater(s): Coimbra, Coimbra, Portugal – Funding: Grant 36. Cureskin Cureskin Cureskin is an all-encompassing service that provides users with simple, tailored solutions with holistic lifestyle guidance to help keep people skin and hair looking healthy. At Cureskin, its mission is to assist people to achieve their sk
How Mediwhale's founder turned personal loss into a healthtech startup | Nicolas Marchand posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to jo
#oculomics #aicardiology #retinalimaging #cardiovascularhealth #glucare #medhiwhale #reti | Idalys Roman Fernandez MD LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or s … insights from the retina. And soon, we’ll be sharing real-world data on how we apply this in clinical practice. 🚀 Next month, I’ll be speaking at our new Educational program on Reti- CVD, where we dive deep into AI-driven retinal screening and its impact on cardiometabolic health. 🔹 Want to know more? Stay tuned! And if you’re as excited as we are about the future of oculomics in cardiology, join us! #Oculomics #AICardiology #RetinalImaging #CardiovascularHealth #Glucare # … . 👨🏫 Guest Editor: Dr. Jackson Liang ( University of Michigan ) 📅 Submission deadline: 31 December 2026 Epicardial access is increasingly used for procedures such as ventricular arrhythmia ablation, left atrial appendage closure, atrial fibrillation, supraventricular tachycardia, and inappropriate sinus tachycardia. We invite submissions on: √ Techniques for obtaining epicardial access √ New tools and devices for epicardial access √Optimal epicardial mapping & ablation
Lost Vision, Found Mission: How Mediwhale’s AI Is Transforming Preventive Healthcare Asia Tech Lens Subscribe Sign in Asia Tech Lens - The Podcast Lost Vision, Found Mission: How Mediwhale’s AI Sees Disease Before Doctors Can 3 1 1× 0:00 Current time: 0:00 / Total time: -32:54 -32:54 Audio playback is not supported on your browser. Please upgrade. Lost Vision, Found Mission: How Mediwhale’s AI Sees Disease Before Doctors Can After losing half his sight to glaucoma at 26, Kevin Choi turned his diagnosis into a company using deep learning and retinal scans to save lives. Asia Tech Lens Nov 04, 2
Mediwhale: This Innovative AI-Powered Health Diagnostics Company Uses Non-Invasive Retina Scans To Prevent Diseases VC PE M&A Asset Management Law Firms Profiles Contact × Search Pulse 2.0 Mediwhale: This Innovative AI-Powered Health Diagnostics Company Uses Non-Invasive Retina Scans To Prevent Diseases By Amit Chowdhry • Sep 21, 2023 Mediwhale: This Innovative AI-Powered Health Diagnostics Company Uses Non-Invasive Retina Scans To Prevent Diseases Mediwhale is an AI-empowered health diagnostics company that uses non-invasive retina scans to help prevent heart and kidney diseases. A
CEO explains how Mediwhale's AI-backed retinal scanning predicts cardiovascular disease risk 주요서비스 바로가기 본문 바로가기 매체정보 바로가기 로그인 바로가기 기사검색 바로가기 전체서비스 바로가기 잠깐! 현재 Internet Explorer 8이하 버전을 이용중이십니다. 최신 브라우저(Browser) 사용을 권장드립니다! ie 인터넷 익스플로러 11 다운로드 chrome 구글 크롬 다운로드 firefox 모질라 파이어폭스 다운로드 상단영역 UPDATE : 2026-06-25 17:01 (Thurs) Home Log in Join 전체메뉴 기사검색 검색 본문영역 이전 기사보기 다음 기사보기 CEO explains how Mediwhale's AI-backed retinal scanning predicts cardiovascular disease risk 바로가기 복사하기 본문 글씨 줄이기 본문 글씨 키우기 스크롤 이동 상태바 현재위치 Home Device/ICT CEO explains how Mediwhale's AI-backed retinal scanning predicts … ands rigorous clinical standards that we are meeting.” Mediwhale plans to submit its De Novo application next year, setting its sights on FDA approval. Reti-CVD is already operational at prominent institutions like Yonsei Severance Hospital and Seoul St. Vincent’s Hospital. Currently, Reti-CVD is an optional, non-covered service. However, if a physician identifies cardiovascular risk, it may be covered. “Although coverage is determined by hospital discretion … forming Biosplice drug in animal tests Comments Log In 작성자 비밀번호 댓글 내용입력 0 / 400 Submit 댓글 정렬 Newest Recommended Top Comments BEST Comments BEST Comments It is automatically exposed by adding up the number of replies and recommendations. 닫기 More Delete comments Deleted comments cannot be recovered. Do you still want to delete it? Password Delete 닫기 Modify the comments You can modify comments only within 1 minute after writing. Text / 400 Password Modify 닫기 My comme
He Lost Half His Vision. Now He's Using AI to Spot Diseases Early. - Business Insider Business Insider Subscribe Newsletters Search Business Strategy Economy Finance Retail Advertising Careers Law Media Real Estate Small Business The Better Work Project Personal Finance Tech Science AI Enterprise Transportation Startups Innovation Markets News Stocks Indices Commodities Crypto Currencies ETFs Lifestyle Entertainment Culture Travel Food Health Education Parenting Military & Defense Politics Reviews Home Kitchen Style Streaming Pets Tech Deals Gifts Tickets Video Big Business So Expensive Vi
Lost Vision, Found Mission: Ho… - Asia Tech Lens - The Podcast - Apple Podcasts Search Home New Top Charts Search November 4, 2025 33 min Lost Vision, Found Mission: How Mediwhale’s AI Sees Disease Before Doctors Can Asia Tech Lens - The Podcast Play In this episode of Asia Tech Lens: Founder Stories , we sit down with Kevin Choi , Co-Founder and CEO of Mediwhale — a Korean healthtech startup using AI to see what doctors can’t. At just 26, Kevin lost half his vision to glaucoma — a silent, asymptomatic disease. Instead of retreating, he turned that diagnosis into a mission: to build an AI syst
How Mediwhale’s AI Sees Disease Before Doctors Can | Asia Tech Lens Podcast with Kevin Choi | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Ca
HeartX Accelerator announces 5 startups for 2022 program | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles
Dr Noon CVD Implemented at Kensington Hospital Johor | Mediwhale posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to L
ADA25: Mediwhale's AI pairs retinal scans, metabolites to refine diabetes risk prediction | FirstWord HEALTHTECH You need to enable JavaScript to run this app. Loading...
#arabhealth2025 | Mediwhale LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Cookie Policy . Skip … al Academy (TMA) , Pan American Health Organization , United Nations Population Fund (UNFPA) , UNITE Parliamentarians Network for Global Health , Medical Women's Federation , Saudi Commission for Health Specialties #Sepsis #AMR #Innovation #CriticalCare #OxygenTherapeutics #SepsisAwareness #SepsisSurvivor #PatientVoices View C2PA information 2 1 Comment Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Fibronostics 3,417 followers 8mo Report this p
[JPM2025] ‘Global pharma showed interest in Mediwhale after we verified AI diagnostic solution Dr. Noon’ | Mediwhale LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or si
[JPM2025] ‘Global pharma showed interest in Mediwhale after we verified AI diagnostic solution Dr. Noon’ | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ P
[바이오USA 2024] 메디웨일 “대뜸 투자 제안 받았죠” | 메디웨일 | 심혈관-대사질환 예방의 새로운 패러다임 메인 콘텐츠 바로가기 메디웨일 제품과 서비스가 궁금하신가요? 회사소개 메디웨일 창업 스토리 리더십 연혁 제품 닥터눈 CVD 닥터눈 Fundus DrNoon (Europe) FAQ 논문 채용 팀 문화 채용공고 뉴스룸 회사 소식 행사 소식 고객 문의 검색 열기 언어 선택 열기 ENG KOR 문의하기 ENG KOR 회사소개 메디웨일 창업 스토리 리더십 연혁 제품 닥터눈 CVD 닥터눈 Fundus DrNoon (Europe) FAQ 논문 채용 팀 문화 채용공고 뉴스룸 회사 소식 행사 소식 고객 문의 문의하기 제목 또는 내용을 검색하세요. 검색 검색 닫기 검색 팝업 닫기 Interview 링크 복사 [바이오USA 2024] 메디웨일 “대뜸 투자 제안 받았죠” 청년의사 2024. 06. 08 최태근 대표, 김수만 글로벌사업본부장 인터뷰 “공동 임상 개발 협의…2026년 미국 진출이 목표” [샌디에이고=김찬혁 기자] 미국 시장 진출을 위한 발판을 마련하고자 ‘바이오 인터내셔널 컨벤션(Bio International Convention, 이하 바이오USA)
VentureRadar 0){if($('#i_b_toggleMore').hasClass('active')){Search_Elastic();}else{Search_DeconstructSearchString();Search_Elastic(false);event.preventDefault();}}else{event.preventDefault();}}" onclick="this.removeAttribute('readonly');" ontouchstart="this.removeAttribute('readonly');" id="i_t_Search" name="VRSearch" readonly> All Ranked Organisation Names Apps and Links Homepage (myVR) Funding Deals Hub Similar Companies App Articles Manage Account Logout Login Free Sign-up Forgotten your password? By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie … de Therapies; Vaccines; Biotech Show more Show less Updates All Funding Insight Grant Award Conference Competition Research Website Traffic Trend Business InsighT 01 Dec 2020 Website traffic has increased in the past 3 months, up from a ranking of 676,733 to 376,314. Source: Data from alexa.com COVID-19 vaccine tracker - London School of Hygiene & Tropical Medicine Research Report 20 Sep 2020 [BioNTech; Fosun Pharma; Pfizer] listed among those developing/researching a COVID-1 … ene therapy to cost $850,000 per patient | Reuters Source: reuters.com The STEP Award (2011) Award 29 Nov 2011 Category Winner: Finances Source: The STEP Award (2011) Show less Funding Signals VENTURE FUNDED Venture-funding News Venture-funding News Venture-funding News Related Top Ranked Companies Lists Life Sciences Biologics Healthtech Sars-Cov-2 Vaccine Cancer Melanoma Immunotherapy Diagnostics Dna Rna Peptide Therapies Vaccines Biotech Website Archive 2022 2023 2024 2025 … search results. Please select a Type Funding Round Team Products & Technologies Grant Award Conference Competition Other {DETAIL_VALUE} Remove Upgrade for full access You have reached your free usage limit for today. Upgrade to a paid plan for: Unlimited search alerts 250 records per export Unlimited pages and searches Full Access from $ 60.00 per month Upgrade Now Your VentureRadar Business account is now active and your account information has been sent to … nditions Privacy Policy Cookie Policy Contact Us Twitter LinkedIn | Submit a Company Directory of Companies Login Free Sign-up for VentureRadar access or By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie Policy . Free Sign-up for VentureRadar access You must have cookies enabled to create an accou
心理压力 - 药物、靶点、专利 - 智慧芽新药情报库 产品 数据 资源 版本对比 预约演示 免费注册 更新于：2025-05-07 Stress, Psychological 心理压力 更新于：2025-05-07 基本信息 别名 Life Stress、 Life Stresses、 Psychologic Stress + [34] 简介 Stress wherein emotional factors predominate. 关联 8 项与 心理压力 相关的药物 Risperidone 利培酮 靶点 5-HT2A receptor x D2 receptor 作用机制 5-HT2A receptor拮抗剂 [+1] 在研机构 Teva Neuroscience, Inc. [+8] 原研机构 Johnson & Johnson 在研适应症 躁郁症1型 [+5] 非在研适应症 急性精神分裂症 [+26] 最高研发阶段 批准上市 首次获批国家/地区 美国 首次获批日期 1993-12-29 Zeller Entspannung film coated tablet 靶点 - 作用机制 - 在研机构 Max Zeller Söhne AG 原研机构 Max Zeller Söhne AG 在研适应症 心理压力 非在研适应症 - 最高研发阶段 批准上市 首次获批国家/地区 … nsidering submitting a rebuttal in the future regarding the FDA decision to not grant a Breakthrough Designation in PTSD. It should also be noted that not being granted this designation does not in any way derail our progress or pathway in our clinical trials or intended operational success. As we continue executing the Phase 3 program in SAD with anticipated readout in Q3 2025, we are also working diligently on exploring ways to enhance efficiencies and foster potential part … ctation that its current cash, cash equivalents, and marketable securities will fund our operations into the third quarter of 2025. The inclusion of forward-looking statements should not be regarded as a representation by Bionomics that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company’s business and other risks described in the Company’s filings with the Secu … new drug discovery Korean pharmaceutical company GI Innovation is pursuing the application of AI for new drug development. It recently signed a memorandum of understanding with local company i-Divine to develop its core cancer drug pipelines and utilise the latter's AI solution to discover new cancer therapy targets. i-Divine's AI is based on a large language model trained on over a billion patents, papers, and real-time biological data sourced globally. It was previously ut … is integrating Philips' heart health monitoring platform into its mobile health application. The AI-based longitudinal triaging solution called HeartPrint tracks and assesses key biomarkers from a person's finger when scanned through their smartphone's camera. These include cardiovascular age, diabetes risk, OSA risk, cardio-respiratory fitness i
American Diabetes Association 2026 - Event Map Event Map We're really glad you decided to visit us today! To ensure the best possible experience, we recommend upgrading to a current browser version. Why should I upgrade? The site will load faster and will render as it was intended to be displayed. I'm pretty sure that I have the latest version of Internet Explorer, but the page doesn't look quite right. You may be viewing the page in compatibility mode, which mimics older versions of Internet Explorer. We recommend turning this off or using another browser for this site for a better user e
FAQ | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Contact us S
AHA Scientific Sessions 2025 Experience Sessions – Page 61 1 60 Table of Contents 62 68 AHA Scientific Sessions 2025 Experience Sessions Experience Scientific Sessions 2025 Final Program 61 Mayo Clinic . . . . . . . . . . . . . . . . . . . .................... 5129 MDisrupt . . . . . . . . . .......... Health Innovation Pavilion 9 Med Learning Group . . . . . . . . . . . . . ............. Lobby G1 Mediwhale . . . . . . . . . . . . . . . . . . . ..................... 4021 Medtronic . . . . . . . . . . . . . . . . . . . .................... 4029 Merck & Co., Inc. . . . . . ....... 3023, 3224
Loop | Tyler Hyungtaek Rim Login Register Javascript disabled: Javascript is disabled in your web browser and this website relies on Javascript to function properly. Please enable Javascript. Tyler Hyungtaek Rim Doctorate Executive (VP, SVP, CFO, CTO etc.) Primary Mediwhale Inc Seoul, Republic of Korea Assistant Professor Duke-NUS Medical School Singapore, Singapore View All 1, attr{'data-test-id' : 'Updated-Affiliation-Primary-' + $index()}">Primary View All Tyler Hyungtaek Rim Overview Bio Network Publications Editorial Contributions Impact Overview Bio Network Publications Editorial Contrib
Big data and artificial intelligence in ophthalmology | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles New
Mediwhale eyes 2025 Saudi launch of AI retinal imaging for heart disease | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediw … r an imminent launch in Saudi Arabia. READ MORE PREV Mediwhale Wins Rising Star Award in AI-Based Patient Care at the 2025 Digital Health Awards NEXT He lost half his vision to glaucoma. Now he’s using AI to help spot disease — but he says tech will never replace doctors. Go to list Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Con
Kevin Taegeun Choi - CEO at Medi Whale | The Org Platform Enrich Pricing Log in Sign up Medi Whale Kevin Taegeun Choi Unverified Kevin Taegeun Choi CEO Contact Kevin Taegeun Choi is the founder and CEO of Mediwhale, a leading digital healthcare company that is the first in offering comprehensive AI diagnostic solutions. His leadership specializes in building an emerging company with strategic planning and business execution. He founded Mediwhale on a mission to bridge the healthcare gap between medical professionals and communities through Mediwhale’s AI diagnostic solutions and empower peop
Uncategorized | 메디웨일 | 심혈관-대사질환 예방의 새로운 패러다임 메인 콘텐츠 바로가기 메디웨일 제품과 서비스가 궁금하신가요? 회사소개 메디웨일 창업 스토리 리더십 연혁 제품 닥터눈 CVD 닥터눈 Fundus DrNoon (Europe) FAQ 논문 채용 팀 문화 채용공고 뉴스룸 회사 소식 행사 소식 고객 문의 검색 열기 언어 선택 열기 ENG KOR 문의하기 ENG KOR 회사소개 메디웨일 창업 스토리 리더십 연혁 제품 닥터눈 CVD 닥터눈 Fundus DrNoon (Europe) FAQ 논문 채용 팀 문화 채용공고 뉴스룸 회사 소식 행사 소식 고객 문의 문의하기 제목 또는 내용을 검색하세요. 검색 검색 닫기 검색 팝업 닫기 심혈관·대사질환 예방의 새로운 패러다임 간편한 눈 검사만으로 질병을 조기 발견하고 예방하는 기술을 개발합니다 핵심 기술 메디웨일은 전신 건강의 창으로 불리는 눈을 통해 우리 몸의 건강 상태를 정밀하게 파악하는 ‘망막 AI’를 개발했습니다. 망막 이미지를 인공지능 기술과 결합한 이 기술은 신속하고 정확하게 각종 질병의 초기 징후를 포착합니다. 이를 바탕으로 조기 진단과 예방 중심의 맞춤형 의료를 실현하여, 보다 건강한 삶을 … 0병상 이상) 수상 이력 2025 Digital Health Awards AI기반 환자 케어 부분 - 라이징 스타 파이널리스트 NextRise Award 2025 탑 이노베이터 어워즈 수상 Digital Health Startups Top 50 세계 디지털 헬스케어 유망 기업 상위 50개 선정 2024 Digital Health Awards 진단 AI 부문 - 라이징스타 쿼터파이널리스트 MICCAI 2024 의료 인공지능 경진대회 - 2개 부문 1위 수상 (당뇨망막병증 식별, 당뇨병성 황반부종 식별) E-nnova Health 2023 Awards 디지털 의료를 통한 환자의 삶의 질을 개선한 기업 - 빅데이터 및 AI 분야 수상 AstraZeneca CKD Challenge 닥터눈 CKD의 만성콩팥질환 위험평가 AI 소프트웨어의 혁신성·우수성 인정 MICCAI 2023 의료 인공지능 경진대회 - 근시성황반병증 부문 3위 수상 2023 CES Inn
40% with some payers). Considering the relevance of cardio-metabolic syndrome, the whole process is simply takes too long, too expensive and dysfunctional. We can now totally reverse this process and get a CACS at step 1. The CE marked solution demonstrated similar risk stratification for cardiovascular events as CT-based CACS, especially over a 5-year follow-up period. Both have a concordance index of 0.71. Our outcomes on this vs standard CT will be published soon. I suspect we’ll find a lot of at-risk patients who would otherwise have been diagnosed using a CT too late (assuming they have a … on Rowberry 1y Report this comment Ihsan Almarzooqi and Ali Hashemi interesting application. Innovation that doesnt drive up healthcare costs 👍👍 Like Reply 1 Reaction 2 Reactions Journey Soyeon Jin 1y Report this comment Thank you Dr. Ihsan Almarzooqi , for sharing GluCare’s innovative approach with Mediwhale ! Like Reply 5 Reactions 6 Reactions Youssef S. Fraiwat 1y Report this comment This is a game changer Like Reply 2 Reactions 3 Reactions
AI-Driven Retinal Imaging for Cardiovascular Risk Stratification in Diabetes—Findings from Ret-CAC Screening at GluCare | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon
--> DrNoon | A New Paradigm of Cardiovascular Disease Preventiont Software top of page Back to Mediwhale Homepage More Use tab to navigate through the menu items. Home DrNoon An artificial intelligence-based software that assists medical personnel by analyzing a patient’s retinal image to detect eye diseases and estimate cardiovascular risk DrNoon is a medical image detection assistant software receives and stores and manages medical image and blood vessel information data of patients. It provides, stores, and manages the results of artificial intelligence(AI) analysis on medical image d
About us | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Contact
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
News | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Contact us … Disease Prevention at AHA 2025 November 4, 2025 News Mediwhale Wins Rising Star Award in AI-Based Patient Care at the 2025 Digital Health Awards October 28, 2025 Interview Mediwhale eyes 2025 Saudi launch of AI retinal imaging for heart disease September 29, 2025 Interview He lost half his vision to glaucoma. Now he’s using AI to help spot disease — but he says tech will never replace doctors. July 7, 2025 News ADA25: Mediwhale’s AI pairs retinal scans, metabolite
CES News - Exhibitor Press Releases CES Media Guides CES Exhibitor Media Center Home Exhibitor Media Kits Press Releases Get News Alerts by Email Order Press Release Posting & Distribution Cision Resources In this section of the CES exhibitor media center, you'll find press releases from CES and exhibitors. The releases are listed in chronological order and are archived by month and year. Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 … at CES 2021" Jan 14, 2021 BOE's active matrix Micro LED wins Innovative Display Application Product Award of the Year at CES 2021 Show 5 10 25 50 100 per page « 1 … 608 609 610 611 612 613 614 … 1248 » Copyright © 2025 Cision Ltd. General Terms & Conditions | Privacy Policy Cookie Policy
%PDF-1.6 %���� 3740 0 obj >stream h��[����W�c�!cI�O�@ro_����f�O��p6N�w����mo��R��N,� o�i��e� t��>v����` 3���L�Vc��y� 9_��.7������{j^,���/>����������~y��>��D}�;"�� � ��(m{� ����x�î�oaZ%aW`�=�G���+��UQ_��R��2�;[g4sͦ/9ҮH�Oۮ��{�s'�ʸ}���ؕi|f�5�8�b+� {�S��q�OmjZ�� K���铱�KKm�>����b߸�w9�%�m%*{{�� �6�[��i����{ۭDcv��7�M}� ��f*m z��9?S���?����ބ� �S;�RRٍw�q� �+�n�vs�� [�fJ��k0{�?�wE���% n�p�QB{aow�0����H�t�\n�� �M �v�v���9 ^�FN:�[�={x ��������r��� �nj��(�㨉�l����{~Ho�7���哭��� �h�� ��U����s�H�t�q?�Z|����c���.��ax�|_C9�� ���x��`�� q� ��� �J�SǴi��#'/��i�#�0_������K … f770358c4b xmp.id:4db24250-d7ef-4a91-a256-7aef0d0542c4 proof:pdf converted from application/x-indesign to application/pdf Adobe InDesign 17.2 (Macintosh) / 2022-10-25T22:24:58-05:00 xmp.iid:c7222f47-38d0-4b16-9748-dc77ff6cb223 xmp.did:78b636c2-e63c-4558-b8a2-7cf770358c4b xmp.did:78b636c2-e63c-4558-b8a2-7cf770358c4b default application/pdf Adobe PDF Library 16.0.7 False endstream endobj 37 0 obj > endobj 38 0 obj >stream H��Um��6�^����\�����J��F]�QW�|���6YT��q6ɿ�I.�]WW �a�y … �5�����j��Mq�1���'�ڰ�V����os���m; ��� 0� � endstream endobj 56 0 obj >stream application/pdf TCT_AHA_CollabLogo 2022-09-27T10:42-05:00 2022-09-27T10:42-05:00 2022-09-27T10:42-05:00 Adobe Illustrator 26.2 (Macintosh) uuid:603289a3-5323-ed43-ae5d-ac7b7390aaec xmp.did:2a414168-f75a-471d-a896-c19cde37ff08 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:350c8a38-acf5-c449-bc2b-0c87093db1d9 xmp.did:e74ee454-51cc-4aab-aa3d-0f9c4287f37c uuid:5D20892493BFDB11914A8590D31508C8 p … ac3854fdb35 xmp.did:78b636c2-e63c-4558-b8a2-7cf770358c4b default converted from application/x-indesign to application/pdf Adobe InDesign 17.2 (Macintosh) / 2022-10-25T22:26:45-05:00 application/pdf Adobe PDF Library 16.0.7 False endstream endobj 88 0 obj > endobj 89 0 obj >stream H��U]��8}_����/����@����IG;R��f��Wc_2�`�ƙ$���#i��Z�HH\�Ǿ�����ۮ'оmt��E �)����7 �q���ݐ@�V���X@��bI)CY �Ѣ�R�E4�]�0�9� 3���(�"˽'0��'q��̽��'n��,� �I�Ov&1���3���Jl7 7�vv����� x!�����0*�) ends … +wz�a��~|C ȧ�x�SD��/�md�� endstream endobj 92 0 obj > endobj 93 0 obj >stream application/postscript Leqvio-logo_GenericOnly_4C_Rball roxy.novo 2022-01-10T15:21:51-05:00 2022-01-10T15:21:51-05:00 2022-01-10T15:21:51-05:00 Adobe Illustrator 25.4 (Macintosh) xmp.iid:55b2b6be-b9b0-40e0-8df4-402b80194aa0 xmp.did:55b2b6be-b9b0-40e0-8df4-402b80194aa0
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
MEDIWHALE INC | Exhibitor | Exposanità Fair Are you an exhibitor? Newsletter Contact English English Italian English English Italian Login Home The Fair – General Information Previous Editions Newsletter Contacts Edition 2026 Media Photo Gallery 2026 Mediakit 2027 Login Are you an exhibitor? Newsletter Contact Exhibitors Why exhibit Exhibitor documents Attention Clicking on "Edit" allows you to insert a brief text that succinctly describes who you are and what you do. Enter the list of your services here. After each word, press enter or click "Add". After entering all the services you want, re
Ophthalmologist Interview | Sahil Thakur LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Cookie … final project was for students to develop a teaching case of their choosing for residency and evaluate it for accuracy, biases, etc. The students used a variety of AI tools that we tested through the course. Y'all, the cases were in a word outstanding! Some thoughts from the students and us: 1. Accurate medical images are still a huge problem. However some AI-powered presentation tools can help with graphics and diagrams ( Napkin.ai and Gamma.app were highlights). 2. The accu
2025 Finalists 2026 Awards Award Categories Awards Timeline Judging Criteria Awards Pavilion @ HLTH About / Team Sponsorship News & Updates Donate 2025 Awards Meet Our Quarterfinalists Meet Our Finalists Meet Our Winners Grand Finale Agenda Awards Timeline Award Categories Sponsorship Opportunities Judging Criteria Awards Pavilion @ HLTH News & Updates About / Team Judges Donate 2024 Grand Finale Agenda Meet our Winners Meet our Finalists Meet our Quarterfinalists Award Categories Judging Criteria Timeline Sponsorship Opportunities Awards Pavilion @ HLTH News & Updates Judges About … unded 2021 Website https://www.pontosense.com Company Name Vori Health CEO Ryan Grant, MD Year Founded 2020 Website https://vorihealth.com Company Name WelFore Health CEO Ann-Marie Austin-Stephens Year Founded 2023 Website https://welforehealth.com/ Meet the Finalists for the Dental / Oral Health Category Click / hover over the logos to find out more about the company. BEST IN CLASS Click to Open Click to Close Company Name DifferentKind CEO Dr. Matt Allen Year Founded 2021 W … g as Asepha) CEO Eunice Wu Year Founded 2023 Website https://www.asepha.ai Home Award Categories Judging Criteria Timeline Sponsorship Opportunities News & Updates About / Team Digital Health Hub Home Donate Contact us Thank you! Thank you for your message, we will be in contact soon! Oops! Something went wrong while submitting the form. Digital Health Hub Foundation © Copyright 2025 The 2021 UCSF Health Awards Show is an event produced by UCSF Health Hub. Judges for the
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Regulatory Archives - Page 23 of 91 - Cardiac Vascular News Follow us twitter linkedin CardiacVascular Executive Search Submit News/Guest Posts Team CardiacVascular Executive Search Submit News/Guest Posts Team The Latest Cardiac and Vascular News Coronary Peripheral EP Neuro Radiology Regulatory Financial Interviews Coronary Peripheral EP Neuro Radiology Regulatory Financial Interviews Regulatory Evkeeza® (evinacumab-dgnb) sBLA for Children with Ultra-rare Inherited Form of High Cholesterol Accepted for FDA Priority Review Coronary/Structural Heart Regulatory November 30, 2022 by Ken Dropiews … gnation for TN-401 is the first for a gene therapy treatment for ARVC Expect to submit TN-401 IND application to the FDA in 2023 SOUTH SAN FRANCISCO, […] Continue Reading → Anteris Technologies Receives FDA Clearance to Initiate Early Feasibility Study for its Novel TAVR Product, DurAVR™ Coronary/Structural Heart Regulatory November 28, 2022 by Ken Dropiewski 0 comments U.S. Clinical Trial Commencement Anticipated in 1Q2023 BRISBANE, Australia & EAGAN, Minn.&#
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
2026 Sponsors | HLTH Europe Event 2027 | Amsterdam USA ViVE SPONSOR About Sponsorship Foundation Who attends Who attends Featured: 2026 speakers Our sponsors Who attends About Attendee breakdown Why attend - Impact report Heard at HLTH Audience Audience snapshot Health systems & providers Payers Government Pharma and life sciences Startups Investors Healthtech, solutions & services Agenda Agenda Featured: 2026 pictures Our sponsors Agenda 2026 speakers 2027 speaker interest Special programming BBC Storyworks Health Transformation Summit Partner Programming Startup pitch Sponsors Sponsors F … 2026 HLTH, INC. All Rights Reserved. × Filter Sessions × Clear All Apply Filters
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
%PDF-1.4 1 0 obj > endobj 3 0 obj > endobj 4 0 obj [/Pattern /DeviceRGB] endobj 6 0 obj > stream ����JFIF����,Photoshop 3.08BIM����� XICC_PROFILE HLinomntrRGB XYZ � 1acspMSFTIEC sRGB���-HP cprtP3desc�lwtpt�bkptrXYZgXYZ,bXYZ@dmndTpdmdd��vuedL�view�$lumi�meas $tech0 rTRC ELRY`gnu|���������������� &/8AKT]gqz������������ !-8COZfr~���������� -;HUcq~��������� +:IXgw��������'7HYj{�������+=Oat������� 2FZn�
Bernard Banga | BioWorld BioWorld. Link to homepage. BioWorld BioWorld Science BioWorld Asia Data Snapshots Biopharma Medical technology Infographics: Dynamic digital data analysis Index insights NME Digest Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A scorecard Bioworld 2025 review BioWorld MedTech 2025 review BioWorld Science 2025 review Women's health China's GLP-1 landscape PFA re-energizes afib market China CAR T Alzhei … s one of 51 innovative technology companies awarded the EIC accelerator program grant, the total budget for which is €261 million (US$286.28 million) in 2023. Read More Sequana reports promising results for its automatic pump to control ascites July 5, 2023 By Bernard Banga Sequana Medical NV has reported additional data on safety, survival and quality of life from its POSEIDON pivotal study in North America, evaluating its Alfapump device used in the treatment of patients wi
Taiwan - Biotech Companies - Careers Page About Directory Promoted Listings Purchase Data Drug Pipelines Data Licensing Weekly Update Newsletter Contact Taiwan - Biotech Companies - Career Pages Therabron Therapeutics , Bought by Brace Pharma Capital Jan 2015 Alkan Pharma , Acquired by Hikma, Apr 2011, $60.5M Singleron Biotechnologies Cologne, Germany Single-Cell Sequencing, Service Lab Twist Bioscience Singapore, Singapore Synthetic DNA, genes and libraries Maxivax , Renamed Release Therapeutics Laboratoires CTRS , Website taken over Nov 2023 - Feb 2024 &nb … nt, and cell bank manufacturing services Vadovations , No info. 2012 SBIR grant Allergy Laboratories , Likely acquired by ALK-Abello, Dec 2016 NanoLive Tolochenaz, Switzerland Cellular Imaging Bristol Myers Squibb New Brunswick, NJ Small Molecules, Biologics Takara Bio USA San Jose, CA Lab products TGA Sciences , Acquired by Absorption Systems, Dec 2017 Sloning Biotechnology , Bought by MorphoSys, Oct 2010, $26.5M Neuroptis Biot … Products, Pharmaceutical Corinth MedTech , Website down Sep 2023; Did not submit annual report in 2022 or 2023 Trek Therapeutics , Shut down Sep 2019 T-Rx Pharmaceuticals , Renamed Adanate, Jul 2018 Marpē Therapeutics , Professor sideline Dyax , Bought by Shire, Jan 2016, $5.9B Avalign Technologies Mentor, OH Orthopedics & Surgical XenoGesis , Acquired by Sygnature Discovery, Oct 2020 Noxilizer Hanover, MD NO2-based Sterilizatio … ow rEVO Biologics 2013 Surface Bioadvances , Website Gone, Aug 2016; SBIR grant Pfizer Kalamazoo, MI Manufacturing Sofpromed Palma de Mallorca, Spain CRO for phase I-IV clinical trials. Regulatory, monitoring, and pharmacovigilance services, Contract Manufacturing Advanced Brain Monitoring Carlsbad, CA EEG headsets, physiological monitoring systems, software Cutting Edge Therapeutics , Website under construction since 2011 SteroTherapeutics … Marizyme, Sep 2020 CERAMIDE THERAPEUTICS , No info. Jun 2015. $1.5M SBIR grant 2011 Trophogen , Very dated website, 2020-Dec 2024 AskBio Durham, NC Cellular & Protein-Based Therapies CellCarta Montréal, QC Clinical Research Breathe BioMedical Cambridge, MA Breath Diagnostics Pozen , Merged with Tribute Pharmac
ADA25: Mediwhale’s AI pairs retinal scans, metabolites to refine diabetes risk prediction | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publicatio
Optain CEO, Founder, Key Executive Team, Board of Directors & Employees Technology Vendors Recent Research Newsletter Media Support Login Who We Serve Function Corporate Strategy Corporate Venture Capital Venture Capital IT Corporate Innovation How VCs Use CB Insights Go to the video gallery → Industries Consumer & Retail Tech Insurance Healthcare Industrials Financial Services Professional Services Professional Services Learn More → Success Stories How We Help Understand Tech Markets Anticipate Competitor Strategy Determine Tech Strategy Connect with Tech Vendors & Partners Turboc
%PDF-1.7 %���� 8011 0 obj > endobj xref 8011 680 0000000016 00000 n 0000041271 00000 n 0000041403 00000 n 0000043123 00000 n 0000043238 00000 n 0000043355 00000 n 0000043470 00000 n 0000043595 00000 n 0000043720 00000 n 0000043836 00000 n 0000043961 00000 n 0000044086 00000 n 0000044211 00000 n 0000044327 00000 n 0000050035 00000 n 0000050074 00000 n 0000050173 00000 n 0000050322 00000 n 0000055584 00000 n 0000062056 00000 n 0000068335 00000 n 0000074819 00000 n 0000074957 00000 n 0000081642 00000 n 0000087336 00000 n 0000093439 00000 n 0000096090 00000 n 0000096204 00000 n 0000096329 00000 n … %:%�$z!:Jw˱�����}��vN��#k��oq�At��� 0�E�[ endstream endobj 8066 0 obj >stream application/pdf BK25_프북_표지 2025-04-23T16:03:03+09:00 2025-04-23T16:03:03+09:00 2025-04-23T16:02:58+10:00 Adobe Illustrator 29.4 (Windows) uuid:ff1ef7e6-c73d-48dc-84e8-55930e0ab56d xmp.did:7f3ce3ef-459e-6d40-b8a1-e918024bb5a2 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:7d58ad0f-8ecc-4776-97f4-216d9be23444 xmp.did:e25559c2-0466-dd40-87b4-ecaff918b087 uuid:5D20892493BFDB11914A8590D31508C8 pr … =�`��eۡ�1 =�]J�I�a,�� �D��� �{��t̷)����O�Or ������� > endobj 77 0 obj >stream application/pdf 광고(182x257mm) 2025-02-27T16:02:59+09:00 2025-02-27T16:02:59+09:00 2025-02-27T16:02:59+10:00 Adobe Illustrator 29.3 (Windows) uuid:759666fc-f6f6-4b30-b554-5910bc6a5fe1 xmp.did:210296f6-b178-0c4f-80a2-449db67fe0c4 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:c6713203-fbd2-4456-80af-1728a95db001 xmp.did:399b822a-9730-2241-8f7e-ea750725f984 uuid:5D20892493BFDB11914A8590D31508C8 … 862A5B75EFB9BC2 xmp.did:AA786FBD914CE511B3C8D03C84CC2EBE default converted from application/x-indesign to application/pdf Adobe InDesign CS6 (Windows) / 2024-04-23T12:48:09+09:00 application/pdf Adobe PDF Library 10.0.1 False endstream endobj 80 0 obj > endobj 81 0 obj >stream H��W[oE�g$��*})�/;��TJ⸭��(� ��6�ժ ��&��? K��68@S�w ���S�W� �ܛn�꒳�IB�����f�0�!2eqܗ�O����� �4���s[蘆z����פx�U��Ȓj_�kr����6��\CЋ�O�ao�XևM X��E]�Z��.f�O��X/���wAQ����9;��ڰ��;��U;O#Mc���W�=H … C�C�C�C��%t8 ���zA�,�K0��B���L��|$?��E�E�E�E�E�E�E�E���`��R�R�Rz* >stream application/pdf BK25_프리뷰북_목차_E 2025-04-11T13:16:06+09:00 2025-04-11T13:16:06+09:00 2025-04-11T13:15:56+10:00 Adobe Illustrator 29.4 (Windows) uuid:d166394c-b1f2-4de4-9eb1-e88728d073bd xmp.did:49099b32-7b5f-c74e-8d14-b5f3d9d52011 uuid:5D20892493BFDB11914A8590D31508C8 p
Publication | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Cont
US11488300B2 - IVUS image analysis method - Google Patents US11488300B2 - IVUS image analysis method - Google Patents IVUS image analysis method Download PDF Info Publication number US11488300B2 US11488300B2 US16/959,886 US201816959886A US11488300B2 US 11488300 B2 US11488300 B2 US 11488300B2 US 201816959886 A US201816959886 A US 201816959886A US 11488300 B2 US11488300 B2 US 11488300B2 Authority US United States Prior art keywords image blood vessel vessel image plaque color Prior art date 2018-01-03 Legal status (The legal status is an assumption and is not a legal conclusion. Google has not p … is and makes no representation as to the accuracy of the status listed.) Active Application number US16/959,886 Other languages English ( en ) Other versions US20210090249A1 ( en Inventor Tae Geun CHOI Geun Yeong LEE Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Mediwhale Inc Original Assignee Mediwhale Inc Priority date (The priority date is an assum … sted.) 2018-01-03 Filing date 2018-12-07 Publication date 2022-11-01 2018-12-07 Application filed by Mediwhale Inc filed Critical Mediwhale Inc 2020-07-02 Assigned to MEDI WHALE INC. reassignment MEDI WHALE INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHOI, TAE GEUN, LEE, GEUN YEONG 2021-03-25 Publication of US20210090249A1 publication Critical patent/US20210090249A1/en 2022-11-01 Application granted granted Critical 2022-11-01 Publication of U … ; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS G16H — HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA G16H30/00 — ICT specially adapted for the handling or processing of medical images G16H30/40 — ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. … ; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS G16H — HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA G16H50/00 — ICT specially adapted for medical diagnosis, medical simulation
Identify Sellers Early with Fintent | Fintent posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agre … ccessfully closed a $37 million oversubscribed financing round led by Structure Fund, with participation from Meiji Seika Pharma Co., Ltd., Sigmas Group, and Kendall Capital Partners, to advance its lead candidate, Centi-Flu 01, through critical clinical phases and support the de... 🏢 Target: Centivax, Inc. 💼 Investor: Structure Fund LP 🔗 Read more: https://lnkd.in/d34QfBRE #MergersAndAcquisitions #PrivateEquity #USPrivateEquity #BusinessGrowth 2 Like Comment Share Copy Li
Leadership | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Conta … He has received multiple prestigious awards, including the Clinician Scientist Award (CSA) and honors from APAO and AAO. Dr. Cheng earned his MD and specialist accreditation in Taiwan, and completed his fellowship and advanced degrees (MPH, PhD) at Johns Hopkins University. Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Copyri
Non-invasive chronic kidney disease risk stratification tool derived from retina-based deep learning and clinical factors | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNo … ble in hypertensive and diabetic conditions . Recently, artificial intelligence application was shown to be capable of providing biomarker estimates, including creatinine, which also led to effective detection of prevalent CKD . In this study, we develop a non-invasive CKD risk stratification tool (“Reti-CKD” score) for people with preserved kidney function, hypothesizing that subtle retinal vasculature changes provide information for future CKD development risk. This is done
Multi-categorical deep learning neural network to classify retinal images: A pilot study employing small database | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Euro
Publication | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Cont
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Mediwhale Secures $13.1M Series C Funding for Global Expansion | GS Capital Connect posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign … on. One sector. One signal. Blackstone just closed BXLS VI, the largest private fund ever dedicated to life sciences, at its hard cap, oversubscribed. That's nearly 40% larger than its predecessor. For us, this is a statement about where capital is going. Since launching its life sciences platform in 2018, Blackstone Life Sciences has backed blockbuster therapies like LEQVIO®, AMVUTTRA®, and IMBRUVICA®, contributed to 34 regulatory approvals, and built an 86% Phase III succes … xist to prepare exactly those professionals. 💬 What does a $6.3B life sciences fund mean for deal flow, valuations, and innovation cycles? We'd love to hear your take. #LifeSciences #PrivateEquity #Biopharma #Healthcare #AlternativeInvestments #ESADE #LSA 15 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Max Zhang 2mo Report this post Neurocrine’s $2.9B buyout of Soleno is the kind of biotech deal the market loves to respect, not celebrate. Why
Data Scientist | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us C … odal Copy URL Data Scientist Development May 29, 2025 This position is open for rolling applications, and results may not be provided immediately. We kindly ask for your understanding. About us: Mediwhale is a pioneering AI healthcare startup focusing on predicting cardiovascular, renal, and metabolic disease (CVRM) risks using retinal biomarkers. The eye is the only organ where blood vessels are directly visible without invasive procedures, which is our key to unlocking unpr … statutory annual leave Support for work-related books and job-related training Application Process: Process: Document screening – 1st interview – 2nd interview – Final Acceptance Tasks may be assigned according to the role, and the interview process may be subject to change. Application documents: Free format (including resume) Please highlight your motivation for applying to Mediwhale, your interest in the position, and your strengths related to the job Interviews: Each int … document return can be made via the recruitment website or at [email protected]. Apply Now Go to list Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Copyright © 2025 Mediwhale Inc. All rights reserved. Privacy Policy Terms of Use 4F, 746 Nonhyeon-ro, Gangnam District, Seoul Linkedin Twiter Facebook Youtube
HLB's Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review - English News1 NEWS1 CONNECT POLITICS DOMESTIC WORLD NORTHKOREA ECONOMY LIFESTYLE ENTERTAINMENT SPORTS Korean Korean | POLITICS DOMESTIC WORLD NORTHKOREA ECONOMY LIFESTYLE ENTERTAINMENT SPORTS Korean POLITICS DOMESTIC WORLD NORTHKOREA ECONOMY LIFESTYLE ENTERTAINMENT SPORTS A Lifestyle HLB's Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review Dae Hyun Moon Updated 2026.03.30 PM 10:01 Top News Loading... © Copyright by News1. All Rights Reserved.
Mediwhale Secures $12M for AI Retina Diagnostics | OBN Categories Breaking News Industry News Ophthalmic Blog Ophthalmic Research News Write for Us Spotlight TV Ophthalmology Glossary Subscribe Home Industry News Mediwhale Secures $12 Million Series A2 Funding for AI-Powered Retina Scan Technology Mediwhale Secures $12 Million Series A2 Funding for AI-Powered Retina Scan Technology October 03, 2024 2967 read --> Mediwhale, an AI-driven diagnostics company, has successfully raised $12 million in Series A2 funding to further develop its retina scanning technology aimed at diagnosing cardiovascul … ces, and practice management. COMPANY About Us Advertise Subscribe Write for Us Submit Press Release Feed LEGAL Cookies Term of Use Privacy Policy CATEGORIES Breaking News Industry News Ophthalmic Blog Ophthalmic Research News Ophthalmology Glossary PREPARED AND PUBLISHED BY Website: www.exon-trading.com Email: [email protected] 8th Floor, On Hing Building, 1 On Hing Terrace – Hong Kong CONTACT US [email protected] Categories Breaking News Industry … Blog Ophthalmic Research News Write for Us Spotlight TV Ophthalmology Glossary Submit Press Release
Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Contact us Search … tal Health Awards Rising Star Finalist for AI in Patient Care Category NextRise Award 2025 Top Innovator Awards Digital Health Startups Top 50 The top 50 most promising digital health companies in the world 2024 Digital Health Awards Quarterfinalists for the Provider Diagnostic Category MICCAI 2024 1st place winner in two categories (Diabetic Retinopathy Identification, Diabetic Macular Edema Identification) E-nnova Health 2023 Awards Winner in the Big Data and AI category fo
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Ophthalmologist Interview – Offbeat, unusual, unconventional & interesting career interviews Skip to content Search for: Search Offbeat, unusual, unconventional & interesting career interviews Research Your Future – Strategic Career Planning for Schools & Colleges Founder Media Subscribe to our newsletter Career Guidance for Schools Podcasts Healthcare , Partially Funded , PathBreakers , Research/PhD , Scholarship , stipend Ophthalmologist Interview Date: February 2, 2025 Author: The Interview Portal 0 Comments Applications of Artificial Intelligence in Ophthalmology ha … ibilities, but I decided to take the NEET exam and was offered an ophthalmology residency in Chandigarh. Ophthalmology is a unique field, it’s all about eyes! It might not be the first thing people think of when they hear “doctor,” but I was always good at technical things, and the idea of performing delicate surgeries under a microscope fascinated me. It felt like a perfect fit! During my residency, I had an incredible mentor, Prof. Parul Ichhpujani, who introduc … s were doing and think differently. That led me to take up an overseas research fellowship in Singapore. Then came COVID-19, and like everyone else, my plans changed. But at that time, I realized I wanted to grow even more as a researcher. I was lucky to find another amazing mentor, Prof. Ching-Yu Cheng, at the Singapore Eye Research Institute, who guided me during my PhD. I did my PhD from Duke-NUS Medical School Duke-NUS (National University of Singapore) Medical School, in … g my MBBS in Chandigarh, where we worked in hospitals while learning. During my residency, we also received a stipend, so technically, I was earning while studying! Later, when I moved to Singapore for my research fellowship, I was again working and studying at the same time. After completing my residency (MS in Ophthalmology), I realized that I needed formal training in clinical research. While I worked on research projects during my medical studies, I often had to rely on e … me feel the need to strengthen my own research skills. During my first research fellowship at the Singapore Eye Research Institute (SERI), I attended research meetings and journal clubs, which further highlighted the gaps in my knowledge of research methodology and statistical analysis. Since self-learning could only take me so far, I decided to
Korean startup Mediwhale secures $12 M to enhance cardiovascular and metabolic disease management HOME Pharma Generics Drug Discovery CMC & Manufacturing Clinical Trials New Drug Applications BioTech Biologics Stem Cells Vaccines Therapeutics MedTech Medical Devices Medical Diagnostic BioServices Contract Research Clinical Research Contract Manufacturing Pre Clinical Development Clinical Trial Phase Healthcare Digital Health COVID19 Artificial Intelligence Healthcare Logistics & Clinical Supply Chain Bio LAB Lab Products Lab Safety Lab Management Lab Design HER Health Cell & Gene S … accept the terms & condition & Privacy policy Sign Up Forgot Password Email id Submit Close × Subscribe To Our Newsletter Email ID I accept the terms & condition & Privacy policy SUBSCRIBE! Close Guía completa para jugadores que buscan una plataforma moderna, segura y entretenida En un mercado digital cada vez más competitivo, los usuarios buscan experiencias que combinen simplicidad, variedad y transparencia. Al explorar opciones de entretenimiento en línea, resulta e … d-time tournaments, confirm that the rules detail how points are earned and how prize pools are distributed. To help you scan core offerings at a glance, review the table below. It summarizes categories that typically influence long-term satisfaction, including user experience, bonus structure, and support availability across devices. Category What to Look For Player Benefit Welcome Bonuses Transparent wagering, reasonable caps, clear eligible games Fair chance to convert bon … lobby, a clear cashier, and readable bet slips can be decisive for players who prize control and visibility. This is one reason experienced users continue to value jokaroom casino online access that feels smooth, uncluttered, and dependable across major browsers. For players comparing platforms, the verdict often rests on two pillars: trust and variety. Licensing details, responsible gambling tools, and transparent payout information build confidence, while a versatile lobby … s includes spins or table chips, the fine print should state where and how they apply. Rolling promos—seasonal tournaments, prize drops, and leaderboard races—keep the lobby fresh without overwhelming you with clutter. Smart players bookmark the terms page and monitor changes, ensuring consistent value before opting in to any new deal. Many reade
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Early Disease Detection: 3 Tech Trends to Watch | AHA Skip to main content Secondary Menu AHA Member Center About Press Center AHA Help Center Search Advocacy Quick Links Action Center Advocacy Agenda Advocacy Issues Action Alerts Special Bulletins Advisories Letters Testimony We Care, We Vote Press Releases Topics Access & Health Coverage Affordability Behavioral Health Compliance Current & Emerging Payment Models Reducing Disparities in Health Outcomes Technology and Cybersecurity Quality and Patient Safety Regulatory Relief Workforce Issues for You The Value of Health Systems The 34 … nce Jun 18, 2026 Applications for AHA’s Rural Hospital Excellence in Innovation Award close June 23 Jun 16, 2026 White House issues executive order on cybersecurity for AI Jun 2, 2026 American Cancer Society updates colorectal cancer screening guidelines, adds blood test option May 27, 2026 AHA podcast: How Hospitals Must Use AI Responsibly May 27, 2026 AHA Healthier Together Conference concludes with sessions on AI, person-centered care May 14, 2026 MACPAC calls for increase … n Session - 2026 Feb 25, 2026 - 12:00 PM - Feb 25, 2026 - 12:45 PM AHA Next Gen Fellowship Information Session - 2026 Feb 18, 2026 - 12:00 PM - Feb 18, 2026 - 01:00 PM AHA Footer About AHA Careers at AHA Membership AHA Online Store Chicago Office: 312.422.3000 D.C. Office: 202.638.1100 AHA Support: 1.800.424.4301 AHA Help Center: Contact Us and FAQs Advocacy Access & Health Coverage Action Center Affordability Behavioral Health Compliance Current & Emerging Payment Mo … y permission into AHA produced materials, created by any third party and cannot grant permission to use, distribute or otherwise reproduce such third party content. To request permission to reproduce AHA content, please click here . --> Noncommercial use of original content on www.aha.org is granted to AHA Institutional Members, their employees and State, Regional and Metro Hospital Associations unless otherwise indicated. AHA does not claim ownership of any content, includin … y permission into AHA produced materials, created by any third party and cannot grant permission to use, distribute or otherwise reproduce such third party content. Request permission to reproduce AHA content.
Mediwhale raises $12M in funding for AI-based retinal scanning tech Search Subscribe Latest Stories Business Legal Pipeline Research Events Products Clinical Articles Ocular Surface Contact Lenses Glaucoma Retina Pediatrics SEE MORE » Jobs Optometrist Jobs Ophthalmologist Jobs Optician & Technician Jobs Hiring Services for Employers SEE ALL JOBS » Virtual Events Upcoming Events Clinical Trials Stories Business Legal Pipeline Research Events Products Archives See All Stories Resources Reports Cheat Sheets Ultimate Guides Calculators & Tools See All Resources Events Courses Jobs Search E … of new shares (where Mediwhale sells shares to investors to use the proceeds to fund its operations) as well as secondary shares (where current shareholders of Mediwhale sell their existing shares). Other investors: Included participation from Woori Venture Partners, IMM Investment, and Mirae Asset Securities, to name a few. Note: This $12 million in Series A2 funding was preceded by Mediwhale raising $2 million in Series Pre-A funding in 2021 and $9 million in Series A fundi … r Articles Personal Finance Practice Management Optometry Students New Graduate Residency Salary & Benefits Events Event Schedule Advertising, Media Kit, & Partnerships Eyes On Eyecare is currently distributing our 2026 media kit and Eyes On event prospectuses. Contact us to learn more about available opportunities - spaces are limited. Media Kit Event Prospectus We're Hiring! Do you work in the eyecare industry? Check out our open positions! Open Positions Eyes
Physics Facts | South Korea built an AI doctor that diagnoses 54 diseases from a single eye scan — in 30 seconds
AI-powered retina scanning startup Mediwhale raises $9M | TechCrunch –:–:–:– The first StrictlyVC of 2026 hits SF on April 30. Tickets are going fast. Register now. Founder Summit ticket savings of up to $190 end June 26. Join 1,000+ founders and VCs for all-day bootcamp. REGISTER NOW. Close TechCrunch Desktop Logo TechCrunch Mobile Logo Latest Startups Venture Apple Security AI Apps Disrupt 2026 Events Podcasts Newsletters Search Submit Site Search Toggle Mega Menu Toggle Topics Latest AI Amazon Apps Biotech & Health Climate Cloud Computing Commerce Crypto Enterpri … treat patients in South Korea for the next two years; afterward, Mediwhale must submit additional clinical data to get a permanent code. It expects to sell its product this summer in South Korea. Mediwhale recently closed $9 million in Series A funding, which brings its total to $12 million since inception. SBI Investment led the latest financing with new investor Woori Venture Partners and previous backers BNK Venture Capital, Innopolis Partners and IPS Ventures participatin
New Partnership with iCare Accelerates Global Adoption of AI for Cardiovascular Risk Prediction | Mediwhale posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking
MediWhale Makes a Big Splash with $12 Million in Funding to Expand Health Diagnostics Technology | Signalbase Signalbase Signals Pricing API docs Login Get API access Login Get API access Toggle menu Funding news · Published September 26, 2024 MediWhale Makes a Big Splash with $12 Million in Funding to Expand Health Diagnostics Technology Recently funded · $12.0M Healthcare Get the full MediWhale company profile Access contacts, investors, buying signals & more Open in Dashboard MediWhale, an innovative leader in AI-powered health diagnostics, has successfully raised $12 million in its lat
Mediwhale secures ₩20 billion in Series C funding, preparing for IPO | Mediwhale LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User
Dr. Noon CVD | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Con
Retinal AI for Cardiovascular Risk Prediction: A U.S. Endocrinologist’s Perspective | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Care
Upcoming events | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us
Life at Mediwhale | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact u
Open roles | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Conta
Life at Mediwhale | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact u
The distribution of artificial intelligence–derived retinal cardiovascular risk scores and conventional risk factors in two Korean health screening cohorts: a descriptive study | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leader
Mediwhale Secures $12 Million in Series A2 Funding to Drive Global Leadership in Cardiovascular and Metabolic Disease Management Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimed … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
Mediwhale partners with Dong-A ST for AI-based retinal imaging | Mediwhale posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you
Publication | Mediwhale | A New Paradigm of Cardometabolic Diseases Prevention Skip to main content Interested in exploring our products? Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Open search Open language selector ENG KOR Contact us ENG KOR Company About us Founder Story Leadership Journey Products Dr. Noon CVD Dr. Noon Fundus DrNoon (Europe) FAQ Publication Careers Life at Mediwhale Open roles Newsroom News Upcoming events Contact us Cont